Correction: Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trial

Affiliations

• ¹ Mater Research Institute, University of Queensland, Brisbane, Australia. t.gurgenci@uq.edu.au.
• ² Department of Supportive and Palliative Care, Mater Health, Brisbane, Australia. t.gurgenci@uq.edu.au.
• ³ Mater Research Institute, University of Queensland, Brisbane, Australia.
• ⁴ QIMR Berghofer Medical Research Institute, Herston, Australia.
• ⁵ Torus Research, Brisbane, Australia.
• ⁶ Department of Medicine, Western Health, Melbourne, Australia.
• ⁷ Grifth University, Nathan, Australia.
• ⁸ Queensland University of Technology, Brisbane, Australia.
• ⁹ Department of Palliative Care, St Vincent's Private Hospital Brisbane, Kangaroo Point, Australia.
• ¹⁰ Department of Supportive and Palliative Care, Mater Health, Brisbane, Australia.